Clinical Trial Update: PF-04449913 For Patients With Acute Myeloid Leukemia at High Risk of Relapse After Donor Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for PF-04449913 in adults with acute myeloid leukemia at high risk of relapse after donor stem cell transplant; study completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• PF-04449913

Snippet

Sponsor: University of Colorado, Denver | Conditions: Adult Acute Myeloid Leukemia in Remission, Recurrent Adult Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2022-01-25